SPDR Advertisement SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

ARNA $6.74

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
QTRADERQ Member Profile
 
Followed By 158
Posts 4,172
Boards Moderated 0
Alias Born 08/12/09
160x600 placeholder
Orexigen: Contrave Scripts Pass 9,000 - Closing In On Qsymia "Seeking Alpha" - 2/23/2015 11:00:10 AM
Arena: Belviq Sales Show Modest Gain - Time To Assess 2015 Expectations? "Seeking Alpha" - 2/23/2015 10:33:39 AM
Arena's Belviq Slows At A Bad Time "Seeking Alpha" - 2/23/2015 9:57:22 AM
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Monday, Ma... "PR Newswire (US)" - 2/23/2015 8:00:00 AM
Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference "PR Newswire (US)" - 2/18/2015 8:00:00 AM
Schedule 13g
(sc 13g/a) "Edgar (US Regulatory)" - 2/12/2015 10:39:37 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/10/2015 11:49:02 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/3/2015 8:46:27 AM
Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management "PR Newswire (US)" - 2/3/2015 5:00:00 AM
Arena Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference "PR Newswire (US)" - 2/2/2015 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/29/2015 2:21:18 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/23/2015 4:52:01 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/23/2015 4:48:33 PM
Arena Pharmaceuticals Announces Agreement to Sell Common Stock "PR Newswire (US)" - 1/21/2015 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/20/2015 5:16:05 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2015 4:17:35 PM
Arena Pharmaceuticals Announces Public Offering of Common Stock "PR Newswire (US)" - 1/20/2015 4:04:00 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) "Edgar (US Regulatory)" - 1/20/2015 4:03:35 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/20/2015 9:01:16 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/12/2015 4:21:38 PM
Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension "PR Newswire (US)" - 1/12/2015 8:00:00 AM
Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV "PR Newswire (US)" - 1/9/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/9/2015 7:32:38 AM
Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune... "PR Newswire (US)" - 1/7/2015 8:00:00 AM
Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference "PR Newswire (US)" - 1/6/2015 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist